Table 2.
Participant |
|||||||
---|---|---|---|---|---|---|---|
A | B | C | D | E | Min | Max | |
Nuclei scored |
100 | 200 | 200 | 200 | 200 | 100 | 200 |
6q- | NA | NA | NA | 6.0 | NA | 6.0 | 6.0 |
11q- | 2.0 | 2.0 | 2.5 | 4.5 | 5.0 | 2.0 | 5.0 |
+12 | 2.0 | 1.0 | 0.5 | 1.0 | 1.5 | 0.5 | 2.0 |
+MDM2 | NA | NA | NA | 10.0 | NA | 10.0 | 10.0 |
13q–x1 | 2.0 | 2.0 | 6.0 | 6.5 | 7.0 | 2.0 | 7.0 |
13q–x2 | 2.0 | 2.0 | 2.5 | 1.0 | 1.5 | 1.0 | 2.5 |
+ LSI13q34 | NA | NA | NA | 10.0 | NA | 10.0 | 10.0 |
17p- | 5.0 | 5.0 | 6.0 | 8.0 | 5.0 | 5.0 | 8.0 |
t(11;14) | 1.0 | 1.0 | 0.5 | 1.0 | 2.0 | 0.5 | 2.0 |
t(14;?) | 2.0 | NA | NA | 8.0 | NA | 2.0 | 8.0 |
Abbreviations: CRC, CLL Research Consortium; Max, maximum; Min, minimum; NA, not available.
Normal cutoff values represent the upper limit of the normal range for each participant and are expressed as percentage of nuclei scored.